Gerry Brunk is a co-founder and Managing Director at Lumira Ventures, a healthcare venture capital firm. He has led investments in multiple biotechnology and medical device companies including enGene, Pharmasset, Engage Therapeutics, MAKO Surgical, KAI Pharmaceuticals, HistoSonics, Endotronix, Satsuma Pharmaceuticals and Cyrano Therapeutics. Prior to beginning his investing career in 2002, Gerry was a founder of several venture-funded healthcare companies, served as an engagement manager in the healthcare practice of Boston Consulting Group, and was a member of the investment banking group of Credit Suisse First Boston. He holds an MBA from Stanford University Graduate School of Business and a BA from the University of Virginia where he studied biology and economics.